TORADOL

This brand name is authorized in Brazil, Canada, Spain, Finland, Hong Kong, Italy, United Kingdom, South Africa

Active ingredients

The drug TORADOL contains one active pharmaceutical ingredient (API):

1 Ketorolac tromethamine UNII 4EVE5946BQ - KETOROLAC TROMETHAMINE

Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration. Read about Ketorolac

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AB15	Ketorolac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 509017020014207
Country: CA	Health Products and Food Branch	Identifier(s): 02162644, 02162660
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58976
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 582250
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 40616
Country: HK	Department of Health Drug Office	Identifier(s): 35309
Country: IT	Agenzia del Farmaco	Identifier(s): 027253020
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/2.7/0570, 28/2.7/0571, 28/2.7/0572